Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline Xcel Energy Inc XEL Bullish Consensus Emerges Following Wall Street Target Raises Ahead of Q1 Earnings AR Antero Q4 2025 EPS misses estimates by 166 percent shares dip 094 percent following quarterly earnings release Dow Inc DOW PostQ1 2026 Earnings Pullback Amid Elevated Valuation and Macro Volatility Deere Company DE PreEarnings Analysis Ahead of Q2 2026 Results